198 related articles for article (PubMed ID: 18608467)
1. Preparation and bioavailability of sustained-release doxofylline pellets in beagle dogs.
Huang HF; Lu Y; He HB; Tang X
Drug Dev Ind Pharm; 2008 Jul; 34(7):676-82. PubMed ID: 18608467
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
[TBL] [Abstract][Full Text] [Related]
4. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
5. Preparation of pH-dependent modified-release pellets of urapidil to improve its bioavailability.
He H; Li H; Tang X
Pharm Dev Technol; 2011 Jun; 16(3):212-8. PubMed ID: 20151942
[TBL] [Abstract][Full Text] [Related]
6. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets.
Gao C; Huang J; Jiao Y; Shan L; Liu Y; Li Y; Mei X
Int J Pharm; 2006 Sep; 322(1-2):104-12. PubMed ID: 16806752
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability.
Xu L; Luo Y; Feng J; Xu M; Tao X; He H; Tang X
Int J Pharm; 2012 Jan; 422(1-2):9-16. PubMed ID: 22001837
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro/in vivo evaluation of esomeprazole magnesium-modified release pellets.
Kan SL; Lu J; Liu JP; Zhao Y
Drug Deliv; 2016; 23(3):866-73. PubMed ID: 24892629
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of levofloxacin sustained-release capsules.
Yin LF; Huang SJ; Jiang SG; Zhao CJ; Pei ZQ; Zhang Q
Drug Dev Ind Pharm; 2011 Jan; 37(1):33-40. PubMed ID: 20545503
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of ofloxacin sustained release pellets.
Cui Y; Zhang Y; Tang X
Int J Pharm; 2008 Aug; 360(1-2):47-52. PubMed ID: 18538518
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of tablets containing enteric-coated diclofenac sodium pellets].
Qi XL; Zhu JB; Chen SJ
Yao Xue Xue Bao; 2008 Jan; 43(1):97-101. PubMed ID: 18357741
[TBL] [Abstract][Full Text] [Related]
12. Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets.
Zhang X; Tang X; Yang R
Drug Dev Ind Pharm; 2009 Jan; 35(1):26-33. PubMed ID: 18686088
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro-in vivo evaluation of double layer coated and matrix sustained release pellet formulations of diclofenac potassium.
Fu J; Wang X; Xu L; Meng J; Weng Y; Li G; He H; Tang X
Int J Pharm; 2011 Mar; 406(1-2):84-90. PubMed ID: 21219996
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.
Guan T; Wang J; Li G; Tang X
Pharm Dev Technol; 2011 Jun; 16(3):269-77. PubMed ID: 20214529
[TBL] [Abstract][Full Text] [Related]
15. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.
Tian L; Zhang Y; Tang X
Drug Dev Ind Pharm; 2008 Jun; 34(6):569-76. PubMed ID: 18568906
[TBL] [Abstract][Full Text] [Related]
16. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
17. Studies of pectin HM/Eudragit RL/Eudragit NE film-coating formulations intended for colonic drug delivery.
Semdé R; Amighi K; Devleeschouwer MJ; Moës AJ
Int J Pharm; 2000 Mar; 197(1-2):181-92. PubMed ID: 10704805
[TBL] [Abstract][Full Text] [Related]
18. Fenofibrate modified-release pellets with lag phase and high oral bioavailability.
Li F; Zheng X; Bao Y; Chen T; Zeng J; Xu X; Yan C; Feng L
Drug Des Devel Ther; 2019; 13():141-151. PubMed ID: 30613135
[TBL] [Abstract][Full Text] [Related]
19. Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating.
Maeda A; Shinoda T; Ito N; Baba K; Oku N; Mizumoto T
Int J Pharm; 2011 Apr; 408(1-2):84-90. PubMed ID: 21291970
[TBL] [Abstract][Full Text] [Related]
20. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
